Radioimmunotherapy as a novel treatment regimen: 125I-labeled monoclonal antibody 425 in the treatment of high-grade brain gliomas
- 31 March 2004
- journal article
- review article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 58 (3) , 972-975
- https://doi.org/10.1016/j.ijrobp.2003.09.096
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- The prognostic impact of prior low grade histology in patients with anaplastic gliomasNeurology, 1996
- Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trialInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Cell cycle dependence of epidermal growth factor induced radiosensitizationInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiformeJournal of Neurosurgery, 1992
- EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURSThe Lancet, 1985
- EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCERThe Lancet, 1985
- Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial originNature, 1985
- Human squamous cell lung cancers express increased epidermal growth factor receptors.Journal of Clinical Investigation, 1984
- Range of Radiochemical Damage to DNA with Decay of Iodine-125Science, 1981